Abstract
aggressive and appropriate fluid and antibiotic therapy. Although bacteria and bacterial products such as endotoxin (LPS, lipopolysaccharide), and exotoxins trigger such catastrophic host responses, mediators produced by the hosts in response to these agents play important roles in producing and propagating the clinical findings associated with sepsis.
Supported in part by grants GM-34695, KO4GM-00505, GM-26145 from the National Institutes of Health.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Wilmore DW, Brennan MF, Harken AH, Holcroft JW, Meakins JL (eds) (1990) Cytokines and the cellular response to injury and infection. In: Care of the Surgical Patient. Scientific American, New York, pp 1–16
Fong Y, Moldawer LL, Shires GT, Lowry SF (1990) The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 170:363–378
Fong Y, Lowry SF (1990) Tumor necrosis factor in the pathogenesis of infection and sepsis. Clin Immunol Immunopath 55:157–170
Fong Y, Tracey KJ, Moldawer LL, et al. (1990) Antibodies to cachectin/TNF reduces interleukin-1ß and interleukin-6 appearance during lethal bacteremia. J Exp Med 170:1627–1633
Fong Y, Marano MA, Moldawer LL, et al. (1990) The acute splanchnic and peripheral tissue metabolic response to endotoxin in man. J Clin Invest 85:1896–1904
Priest BP, Brinson DN, Schroeder DA, Dunn DL (1989) Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysac-charide. Surgery 106:147–155
Mayoral JL, Schweich CJ, Dunn DL (1990) Decreased tumor necrosis factor production during the initial stages of infection correlates with survival during murine gram-negative sepsis. Arch Surg 125:24–28
Dunn DL, Priest BP, Condie RM (1988) Protective capacity of polyclonal and monoclonal antibodies directed against endotoxin during experimental sepsis. Arch Surg 123:1389–1393
Danner RL, Joiner KA, Parrillo JE (1987) Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X. J Clin Invest 80:605–612
Billiar TR, Bankey PE, Svingen BA, et al. (1988) Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 104:343–349
Endres S, Ghorbani R, Kelley VE, et al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265–271
Fong Y, Marano MA, Barber A, et al. (1989) Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in man. Ann Surg 210:449–457
Moldawer LL, Marano M, Wei H, et al. (1989) Cachectin/tumor necrosis factor-alpha, but not interleukin 1 alpha alters red blood cell kinetics and induces anemia in vivo. FASEB Jour 3:1637–1643
McBride WH, Economou JS, Nayersina R, Coora S, Essner R (1990) Influences of interleukin 2 and 4 on tumor necrosis factor production by urine mononuclear phagocytes. Cancer Research 50:2949–2952
Jansen JH, Fibbe WE, Willemze R, Kluin-Nelemans JC (1990) Interleukin-4: a regulatory protein. Blut 60:269–274
Beutler B, Milsark IW, Cerami A (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science (Washington DC) 229:869–871
Mathison JC, Wolfson E, Ulevitch RJ (1988) Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81:1925–1937
Tracey KJ, Fong Y, Hesse DG, et al. (1987) Anti-cachectin/TNF antibodies prevent the fatal sequelae of experimental bacteremia in primates. Nature 330:662–664
Hinshaw L, Olson P, Kuo G (1989) Efficacy of post-treatment with anti-TNF monoclonal antibody in preventing the pathophysiology and lethality of sepsis in the baboon. Circ Shock 27:362
Fong Y, Moldawer LL, Marano M, et al. (1989) Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am J Physiol 256:R659–665
Novick D, Engelmann H, Wallach D, Rubinstein M (1989) Soluble cytokine receptors are present in normal human urine. J Exp Med 170:1409–1414
Velio B (1990) Catabolism of therapeutic proteins and peptides with implications for drug delivery. Advanced Drug Delivery Reviews 4:149–169
Gershenwald JE, Fong Y, Chizzonite R, Lowry SF, Moldawer LL (1990) The metabolic response to inflammation is attenuated by anti-interleukin-1 receptor monoclonal antibodies. In: Powanda M et al. (eds) Molecular and cellular biology of cytokines. Alan R. Liss, New York, pp 441–446
Gershenwald JE, Fong Y, Fahey III TJ, et al. (1990) Interleukin-1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 87:4966–4970
Chizzonite R, Truitt T, Kilian PL, et al. (1989) Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci USA 86:8029–8033
Dinarello CA, Clark BD, Puren AJ, Savage N, Rosoff PM (1989) The interleukin-1 receptor. Immunol Today 10:49–51
Curran RD, Billiar TR, Stuehr DJ, Ochoa JB, Harbrecht BG, Flint SG, Simmons RL (1990) Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 212:462–471
Kilbourn RG, Gross S, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for involvement of nitric oxide. Proc Natl Acad Sci USA 87:3629–3632
Michie HR, Manogue KR, Spriggs DR, et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481–1486
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Fong, Y., Lowry, S.F. (1991). Modulation of the Cytokine Response in Sepsis. In: Vincent, J.L. (eds) Update 1991. Update in Intensive Care and Emergency Medicine, vol 14. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84423-2_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-84423-2_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53672-7
Online ISBN: 978-3-642-84423-2
eBook Packages: Springer Book Archive